Blog Archives

(B)3-Bad Science, Bad Pharma…now Bad Guidelines

Category: Access, General | Tagged , , , , , , , , | Leave a comment

Getting serious about registering and reporting trials – alltrials.net

Category: Access, General | Tagged , , , , , , | Leave a comment

Now is the time for transparency and access to clinical-trial data

Category: Access | Tagged , , , , , , , , , | Leave a comment

India’s patent law on trial

Category: General | Tagged , , , , | Leave a comment

Industry’s Influence

Category: Drug Development, Housekeeping, Industry funding | Tagged , , , , , , , | Leave a comment

Do No Harm: How a US-Led Free Trade Agreement Threatens the Prospects for an AIDS-Free Generation

Category: AIDS2012 | Tagged , , , , , , , , , , | Leave a comment

This Week in PLOS Medicine: Pharma research; ART & TB; Gestational diabetes & more

Category: PLoS Medicine Week by Week | Tagged , , , , , , | Leave a comment

GlaxoSmithKline found guilty while complicit physicians remain unscathed

Category: General, Policy | Tagged , | Leave a comment

This Week in PLoS Medicine: Clinical prediction research; Improving drug formularies

Category: PLoS Medicine Week by Week | Tagged , , , , | Leave a comment

This Week in PLoS Medicine: Metformin efficacy; Food insecurity & HIV risk; Sharing clinical study reports & more

Category: PLoS Medicine Week by Week | Tagged , , , , , , , | Leave a comment